Synaura

Synaura, founded in Zhangjiang, Shanghai in 2022, is a bio-manufacturing company equipped with advanced synthetic biology technology. The company mainly focuses on the research and development of synthetic biology methods and is committed to applying them to large-scale production. It is a leading domestic producer of HMO in China. Currently, Synaura has established a vast bio-resource engineering library platform and has accumulated extensive experience in biosynthesis, intelligent design of high-performance cell factories, and large-scale production of products. Synaura envisions a portfolio of more than 10 investments, covering fields such as biomedicine, agriculture, and health foods.